Trading at a relative discount to industry peers, suggesting a specific risk premium is applied.
High-quality fundamentals with a strong composite quality score of 76/100, backed by robust profitability and solvency.
Wall Street forecasts a balanced outlook with consensus price targets near the current price.
Verdict: Solid fundamental quality, though profitability presents a headwind.
Wall Street sentiment is generally neutral alongside robust expected earnings growth. This is paired with healthy capital returns, anchored by a strong, well-covered dividend yield.
SGHC demonstrates strong business quality with robust profitability and healthy margins (highlighted by a massive 101.7% ROIC). This is backed by a fortress balance sheet, holding significant net cash ($438M) and minimal debt risk.
The company is driving exceptional top-line expansion (17.2% 3Y CAGR) paired with stable bottom-line earnings. The company maintains healthy operational efficiency with a 19.9% operating margin.
| Financial Metric | Trend (12Q) | Latest Qtr | 1Y Growth | 3Y CAGR | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| Revenue | $612.0M | +31.4% | +17.2% | +19.7% | — | |
| EBITDA | $142.0M | — | +37.8% | — | — | |
| Net Income | $87.0M | +91.8% | +3.7% | — | — | |
| EPS (Diluted) | $0.17 | +95.5% | +5.1% | +11.5% | — | |
| Free Cash Flow | $89.0M | +63.3% | +32.8% | +18.5% | — |
| Metric | TTM | 3Y Avg | 5Y Avg | 10Y Avg |
|---|---|---|---|---|
| Gross Margin | 28.4% | 41.1% | 46.5% | 49.1% |
| Operating Margin | 19.9% | 13.3% | 12.3% | 9.1% |
| Net Margin | 10.3% | 5.2% | 9.5% | 8.6% |
| FCF Margin | 4.0% | 10.6% | 10.8% | 9.9% |
| Quarter | EPS Est. | EPS Act. | Surprise | EPS | Rev |
|---|---|---|---|---|---|
| Q2'26Latest | $0.17 | $0.17 | -2.1% | ||
| Q2'26 | $0.17 | $0.13 | -25.4% | ||
| Q1'26 | $0.14 | $0.13 | -6.8% | ||
| Q4'25 | $0.14 | $0.19 | +35.7% | ||
| Q3'25 | $0.13 | $0.11 | -15.4% | ||
| Q3'25 | $0.13 | $-0.01 | -104.6% | ||
| Q2'25 | $0.09 | $0.12 | +33.3% | ||
| Q2'25 | $0.16 | $0.13 | -18.8% |
Total return is +40.5% (1Y), outperforming the benchmark by +15.5%
| Period | Total Return | vs S&P 500 (Alpha) | Dividend Contribution |
|---|---|---|---|
| YTD | +17.0% | +7.7% | — |
| 1Y | +40.5% | +15.5% | +4.3% |
| 3YCAGR | +52.3% | +33.4% | +17.9% |
| 5YCAGR | +6.8% | -5.6% | +7.0% |
| 10YCAGR | +3.7% | -9.8% | — |
The S&P 500 is at 31.3x trailing P/E — Expensive relative to historical averages.
Quick answers to common questions about Super Group (SGHC) Limited (SGHC) valuation, health, and returns.
Super Group (SGHC) Limited is estimated to be fair under our discounted cash flow framework. relative multiples indicate the stock is Cheap versus peers compared to industry peers. trading near fair value (DCF: $12.34)
Super Group (SGHC) Limited has multiple valuation anchors: DCF Intrinsic Value: $12.34 | Peer Relative Fair Value: $19.52 | Wall Street Analyst Target: $13.71 (implying +2.9% upside). A convergence of these signals offers higher conviction.
Super Group (SGHC) Limited displays good financial health with a composite quality score of 76/100, supported by a Altman Z-Score of 12.3 (safe zone), Piotroski F-Score of 7/9, Return on Invested Capital (ROIC) of 101.7%.
Super Group (SGHC) Limited pays a 2.3% dividend yield, covered by a 72% payout ratio with 2 years of growth, supplemented by a 0.0% buyback yield.
Super Group (SGHC) Limited's current growth trajectory is Accelerating. The company achieved +31.4% 1Y revenue growth and +95.5% 1Y EPS growth, compared to its 3Y revenue CAGR of +17.2%.
Wall Street consensus is Buy based on 8 analysts, beating EPS expectations in 33% of recent quarters with a -3-quarter streak. The consensus price target represents a +2.9% change from current levels.
Investment risks for Super Group (SGHC) Limited include: -39.5% 1-year max drawdown. Volatility risk is characterized by a beta of 0.99x.
No. These computations are purely quantitative model outputs for informational purposes. They do not account for qualitative management shifts or macro events. Always consult a licensed RIA before buying or selling shares.
Disclaimer: This page is for informational purposes only and does not constitute financial advice. All valuation models, scores, and target estimates are automated computations under stated assumptions and should not be relied upon as the sole basis for any investment decision.